Alembic Pharma Secures Approval to Manufacture Generic Psoriasis Drug

Alembic Pharmaceuticals announced on Monday that it has received approval from the US Food & Drug Administration (USFDA) to market a generic version of Betamethasone Valerate Foam, a medication used to treat moderate-to-severe psoriasis of the scalp.

Sun Pharma Launches Novel Treatment in India

Sun Pharmaceutical Industries Limited introduced tedizolid phosphate tablets 200 mg in India with the brand name "Starizo". Starizo (tedizolid phosphate) is a new antibiotic in the oxazolidinone class, prescribed for acute bacterial skin and skin...

Serum Institute of India in Works to Develop Vaccine for Mpox

Adar Poonawalla, CEO of Serum Institute of India (SII), has announced that the company is working on developing a vaccine for Mpox, with expectations of a "positive outcome" within a year. This development comes in response to the global Mpox outb...

Titan Pharma Forays into Merger Agreement with KE Sdn. Bhd.

Titan Pharmaceuticals, Inc. has revealed that it is engaged in a Merger and Contribution and Share Exchange Agreement for a business merger with KE Sdn. Berhad. The board of directors of Titan approved the Merger Agreement. If Titan's and KE's...

Pharma Dept. to Introduce Scheme Boosting Domestic Equipment Manufacturing

A new scheme aimed at bolstering the domestic medical device industry will be launched within the next month, according to Arunish Chawla, Secretary of the Department of Pharmaceuticals. The scheme is currently being finalized following extensive ...

Gilead Sciences and PANTHERx Partner for LIVDELZI distribution

Gilead Sciences has collaborated with PANTHERx Rare to provide LIVDELZI, a medication aimed at adults suffering from primary biliary cholangitis (PBC). The goal of the partnership is to offer patients the specific peroxisome proliferator-activated...

Domestic Pharmaceutical Retail market rises 11 percent in July

In July, the domestic pharmaceutical retail market witnessed a remarkable 11 percent increase. This phenomenon can be referred to as the flu impact. Increased sales of anti-infectives and pain relief suggest a rise in cases of flu and other viral...

Orchid Pharma Achieves Over Threefold Increase in Q1 2024 Net Profit

Orchid Pharma announced a consolidated net profit of Rs. In the first quarter ending on June 30, 2024, the revenue increased by over three times to Rs 32.95 crore, exceeding the Rs 9.4 crore recorded in the same quarter of the previous fiscal...

Need for Intrapreneurship in the MedTech Sector

In an exclusive interview with India Pharma Outlook, Sunil Joshi, Managing Director, Getinge India, shares his insights on how intrapreneurial culture is changing how innovation is carried out within organizations, the demands of the market drivin...

Podiatry Medicine in India's Decoding Challenges and Potential

Not many of you would be aware of Podiatry as a stream of healthcare and medicine. This medical specialty is aimed exclusively at the diagnosis, treatment, and prevention of foot and ankle disorders, ranging from trauma, and sports injuries, to ev...